Erlander Mark 4
4 · Cardiff Oncology, Inc. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Erlander Mark
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2021-06-10+435,072→ 815,272 totalExercise: $7.98Exp: 2031-06-10→ Common Stock (435,072 underlying)
Footnotes (1)
- [F1]108,768 vest on 6/10/2022. 9,064 vest monthly for 36 months beginning on 7/10/2022 through 6/10/2025.